STAT+: Biotech investors plea to Trump, and a busy...

What’s Happening

Okay so Smaller biotechs move to negotiate with White House, medicine’s trust gap, and other biotech news from The Readout Exclusive Exclusive STAT Plus: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House By Daniel Payne Biotech Biotech STAT Plus: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts By Daniel Payne The Readout The Readout STAT Plus: Lillys obesity pill enters the oral GLP-1 game, Novo responds By Meghana Keshavan Adams Biotech Scorecard Adams Biotech Scorecard STAT Plus: ‘Takeover Tuesday’ saves biotechs quarter By Adam Feuerstein Biotech Biotech STAT Plus: Trump administration prepares 100% tariffs on some imported drugs By Daniel Payne STAT Plus: How a Texas couple is getting rich off out-of-network medical bills By Tara Bannow STAT Plus: Ba hit speed bump in quest to grow custom gene editor By Jason Mast STAT Plus: In private meetings, White House works to win pharma companies support for drug pricing bill By Daniel Payne STAT Plus: HSA companies struck it big in Trump’s tax bill.

More details are expected to emerge soon.

Why This Matters

Health experts are weighing in on what this means for people.

Medical professionals are taking note of this development.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

We want to hear your thoughts on this.